ASTALLTDPharmaceuticals
Astal Laboratories Ltd — Quarterly Results & Earnings
₹65.36
+0.94%
Profit Growth YoY29.00%Latest quarter
Sales Growth YoY185.11%Latest quarter
Sales CAGR 5YN/A5 year compound
Profit CAGR 5Y212.84%5 year compound
📋
Quarterly Performance
YoY Profit Growth+29.00%
🔥 Exceptional growth
YoY Sales Growth+185.11%
🔥 Exceptional growth
OPM 5Y Average
15.05%Operating profit margin
EPS Growth 5Y
161.53%Interest Coverage
12.32Higher = safer debt servicing
ROE
30.10%ROCE
34.78%💡
Growth Analysis
Astal Laboratories Ltd reported YoY profit growth of 29.00% and revenue growth of 185.11% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at 212.84% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Astal Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.